Medical News

RSS

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo Company today announced results for its first quarter ended September 26, 2009.

2 Nov 2009

Perrigo to sell its Israel Consumer Products business to Emilia Group

Perrigo Company today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in Israel to Emilia Group, a subsidiary of O. Feller Holdings Ltd., for 205 million New Israeli Shekels (approximately $54 million).

2 Nov 2009

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.

2 Nov 2009

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.

2 Nov 2009

New on-line job resource center launched by NAWC

The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.

2 Nov 2009

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

Historic agreement sets national standard for containing the spread of H1N1

In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."

2 Nov 2009

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.

2 Nov 2009

Kinetic Concepts receives approval from MHLW in Japan to sell its V.A.C. Therapy System

Kinetic Concepts, Inc. announced today that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted final regulatory approval for KCI to market and sell its innovative V.A.C.® Therapy System in the country.

2 Nov 2009

Vanda Pharmaceuticals announces financial results for the third quarter of 2009

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the third quarter ended September 30, 2009.

2 Nov 2009

First Edition: November 2, 2009

Today's headlines feature insights into President Obama's behind-the-scenes role in advancing the Democrats' health overhaul efforts in Congress, plus more analysis of the public insurance option.

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has secured $30.2 million in Series B financing. ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.

2 Nov 2009

First human robot assisted aortic valve replacement to implant the ATS 3f Aortic Bioprosthesis performed

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced the first human robot assisted endoscopic aortic valve replacement using the daVinci® Surgical System from Intuitive Surgical to implant the ATS 3f® Aortic Bioprosthesis. The procedure was performed by Allen Raczkowski, M.D., at Banner Baywood Health Hospital in Phoenix, Arizona.

2 Nov 2009

Deep brain stimulation can help patients with severe forms of depression

In deep brain stimulation, doctors specifically target the impaired function of certain areas of the brain with an electric brain pacemaker. For the purpose of this study, they implanted electrodes in what is known as the nucleus accumbens. That is an important part of the 'reward system' which ensures that we remember good experiences and puts us in a state of pleasant anticipation.

2 Nov 2009

MTD Products and AHA team up to promote heart health and winter safety

What do sipping cocoa, snuggling under blankets and heart attacks all have in common? They are all more common during the cold winter months.

2 Nov 2009

Virtual world solution to address the unique needs of military amputees

Virtual worlds can provide military amputees with an opportunity to enhance their overall quality of life, expedite their reintegration into society, and improve their physical and mental wellness.

2 Nov 2009

Optics industry reinventing itself through personalized service logistics solutions

GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.

2 Nov 2009

Medela to host Virtual Human Milk Collection Campaign

Medela today announced it will host a Virtual Human Milk (breastmilk) Collection Campaign in honor of the March of Dimes' National Prematurity Awareness Month and the thousands of dedicated Neonatal healthcare professionals nationwide.

2 Nov 2009

Metro Dentalcare sponsors Halloween candy buyback event

Halloween candy is a sweet treat for kids and a nightmare for parents, but this Halloween, kids can turn their goodies into cash and donations for charities. Thirteen Metro Dentalcare locations around the Twin Cities are sponsoring Halloween candy buybacks on Nov. 2.

2 Nov 2009